Neil Morrey

Gentronix Ltd. provides services and solutions to help organizations optimize the development of drugs and other chemicals. It provides contract services for genotoxicity using a patented human cell GADD45a reporter GreenScreen HC and BlueScreen HC assays and related assays including Micronucleus and Ames MPF. The company was founded by Richard Maurice Walmsley in July 1999 and is headquartered in Macclesfield, the United Kingdom.

Reaxa Ltd. manufactures and distributes products and technologies for the chemical industry. Its products include EnCat, QuadraPure, QuadraSil and LaPCat. The company was founded by Steven V. Ley, Ian R. Baxendale and Peter Jackson in 2004 and is headquartered in Manchester, the United Kingdom.

Capital for Enterprise Fund Managers Ltd is a private equity firm founded in 2008. The firm is headquartered in the UK.

Clean Power Hydrogen Group Ltd. develops hydrogen production and storage equipment. The company was founded on July 19, 2016 and is headquartered in London, the United Kingdom.

Synexus Clinical Research Ltd. offers clinical trials and biological research services. It offers clinical trial management, project management, medical imaging and medical procedures. The company was founded in 1998 and is headquartered in Lancashire, the United Kingdom.

Future Meds Ltd. is a fast-growing independent research site network that supports pharmaceutical companies, sponsors, and CROs in finding effective treatments and medications for patients. The private company is based in Bromborough, UK, and has subsidiaries in Germany and the United Kingdom. The British company's dedicated research site teams aim to accelerate study timelines, streamline processes, lower costs, and improve data quality to help patients access new treatments faster. Future Meds is a network of modern dedicated research sites that conduct clinical trials using innovative technologies to make them available to as many patients as possible. The company was founded in 2020, and Radoslaw Janiak has been the CEO since 2019.